1277 related articles for article (PubMed ID: 34704457)
1. Deficient Chaperone-Mediated Autophagy Promotes Inflammation and Atherosclerosis.
Qiao L; Ma J; Zhang Z; Sui W; Zhai C; Xu D; Wang Z; Lu H; Zhang M; Zhang C; Chen W; Zhang Y
Circ Res; 2021 Dec; 129(12):1141-1157. PubMed ID: 34704457
[TBL] [Abstract][Full Text] [Related]
2. Activation of NLRP3 inflammasomes contributes to hyperhomocysteinemia-aggravated inflammation and atherosclerosis in apoE-deficient mice.
Wang R; Wang Y; Mu N; Lou X; Li W; Chen Y; Fan D; Tan H
Lab Invest; 2017 Aug; 97(8):922-934. PubMed ID: 28394319
[TBL] [Abstract][Full Text] [Related]
3. Novel Role for Tranilast in Regulating NLRP3 Ubiquitination, Vascular Inflammation, and Atherosclerosis.
Chen S; Wang Y; Pan Y; Liu Y; Zheng S; Ding K; Mu K; Yuan Y; Li Z; Song H; Jin Y; Fu J
J Am Heart Assoc; 2020 Jun; 9(12):e015513. PubMed ID: 32476536
[TBL] [Abstract][Full Text] [Related]
4. Polydatin protects against atherosclerosis by activating autophagy and inhibiting pyroptosis mediated by the NLRP3 inflammasome.
Zhang X; Wang Z; Li X; Chen J; Yu Z; Li X; Sun C; Hu L; Wu M; Liu L
J Ethnopharmacol; 2023 Jun; 309():116304. PubMed ID: 36870461
[TBL] [Abstract][Full Text] [Related]
5. Fucoidan Inhibits NLRP3 Inflammasome Activation by Enhancing p62/SQSTM1-Dependent Selective Autophagy to Alleviate Atherosclerosis.
Cheng Y; Pan X; Wang J; Li X; Yang S; Yin R; Ma A; Zhu X
Oxid Med Cell Longev; 2020; 2020():3186306. PubMed ID: 33505579
[TBL] [Abstract][Full Text] [Related]
6. Nur77 Deficiency Exacerbates Macrophage NLRP3 Inflammasome-Mediated Inflammation and Accelerates Atherosclerosis.
Yuan R; Zhang W; Nie P; Lan K; Yang X; Yin A; Xiao Q; Shen Y; Xu K; Wang X; Pan X; Shen L; He B
Oxid Med Cell Longev; 2022; 2022():2017815. PubMed ID: 35464766
[TBL] [Abstract][Full Text] [Related]
7. Tanshinone IIA attenuates atherosclerosis via inhibiting NLRP3 inflammasome activation.
Wen J; Chang Y; Huo S; Li W; Huang H; Gao Y; Lin H; Zhang J; Zhang Y; Zuo Y; Cao X; Zhong F
Aging (Albany NY); 2020 Nov; 13(1):910-932. PubMed ID: 33290264
[TBL] [Abstract][Full Text] [Related]
8. Cereal Fiber Ameliorates High-Fat/Cholesterol-Diet-Induced Atherosclerosis by Modulating the NLRP3 Inflammasome Pathway in ApoE
Zhang R; Han S; Zhang Z; Zhang W; Yang J; Wan Z; Qin L
J Agric Food Chem; 2018 May; 66(19):4827-4834. PubMed ID: 29664631
[TBL] [Abstract][Full Text] [Related]
9. Endothelial Foxp1 Suppresses Atherosclerosis via Modulation of Nlrp3 Inflammasome Activation.
Zhuang T; Liu J; Chen X; Zhang L; Pi J; Sun H; Li L; Bauer R; Wang H; Yu Z; Zhang Q; Tomlinson B; Chan P; Zheng X; Morrisey E; Liu Z; Reilly M; Zhang Y
Circ Res; 2019 Aug; 125(6):590-605. PubMed ID: 31318658
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-155 promotes the ox-LDL-induced activation of NLRP3 inflammasomes via the ERK1/2 pathway in THP-1 macrophages and aggravates atherosclerosis in ApoE-/- mice.
Yin R; Zhu X; Wang J; Yang S; Ma A; Xiao Q; Song J; Pan X
Ann Palliat Med; 2019 Nov; 8(5):676-689. PubMed ID: 31865729
[TBL] [Abstract][Full Text] [Related]
11. NLRP3 Inflammasome Inhibition by MCC950 Reduces Atherosclerotic Lesion Development in Apolipoprotein E-Deficient Mice-Brief Report.
van der Heijden T; Kritikou E; Venema W; van Duijn J; van Santbrink PJ; Slütter B; Foks AC; Bot I; Kuiper J
Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1457-1461. PubMed ID: 28596375
[TBL] [Abstract][Full Text] [Related]
12. Specific NLRP3 Inhibition Protects Against Diabetes-Associated Atherosclerosis.
Sharma A; Choi JSY; Stefanovic N; Al-Sharea A; Simpson DS; Mukhamedova N; Jandeleit-Dahm K; Murphy AJ; Sviridov D; Vince JE; Ritchie RH; de Haan JB
Diabetes; 2021 Mar; 70(3):772-787. PubMed ID: 33323396
[TBL] [Abstract][Full Text] [Related]
13. Melatonin Ameliorates the Progression of Atherosclerosis via Mitophagy Activation and NLRP3 Inflammasome Inhibition.
Ma S; Chen J; Feng J; Zhang R; Fan M; Han D; Li X; Li C; Ren J; Wang Y; Cao F
Oxid Med Cell Longev; 2018; 2018():9286458. PubMed ID: 30254716
[TBL] [Abstract][Full Text] [Related]
14. Metformin inhibited Nod-like receptor protein 3 inflammasomes activation and suppressed diabetes-accelerated atherosclerosis in apoE
Tang G; Duan F; Li W; Wang Y; Zeng C; Hu J; Li H; Zhang X; Chen Y; Tan H
Biomed Pharmacother; 2019 Nov; 119():109410. PubMed ID: 31518877
[TBL] [Abstract][Full Text] [Related]
15. Autophagy in Atherosclerotic Plaque Cells: Targeting NLRP3 Inflammasome for Self-Rescue.
Li X; Zhu X; Wei Y
Biomolecules; 2022 Dec; 13(1):. PubMed ID: 36671400
[TBL] [Abstract][Full Text] [Related]
16. NLRP3 Inflammasome Activation Controls Vascular Smooth Muscle Cells Phenotypic Switch in Atherosclerosis.
Burger F; Baptista D; Roth A; da Silva RF; Montecucco F; Mach F; Brandt KJ; Miteva K
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008765
[TBL] [Abstract][Full Text] [Related]
17. Cholesterol Efflux Pathways Suppress Inflammasome Activation, NETosis, and Atherogenesis.
Westerterp M; Fotakis P; Ouimet M; Bochem AE; Zhang H; Molusky MM; Wang W; Abramowicz S; la Bastide-van Gemert S; Wang N; Welch CL; Reilly MP; Stroes ES; Moore KJ; Tall AR
Circulation; 2018 Aug; 138(9):898-912. PubMed ID: 29588315
[TBL] [Abstract][Full Text] [Related]
18. Rutaecarpine derivative R3 attenuates atherosclerosis via inhibiting NLRP3 inflammasome-related inflammation and modulating cholesterol transport.
Luo J; Wang X; Jiang X; Liu C; Li Y; Han X; Zuo X; Li Y; Li N; Xu Y; Si S
FASEB J; 2020 Jan; 34(1):1398-1411. PubMed ID: 31914630
[TBL] [Abstract][Full Text] [Related]
19. miR-155 activates the NLRP3 inflammasome by regulating the MEK/ERK/NF-κB pathway in carotid atherosclerotic plaques in ApoE
Peng Q; Yin R; Zhu X; Jin L; Wang J; Pan X; Ma A
J Physiol Biochem; 2022 May; 78(2):365-375. PubMed ID: 35079982
[TBL] [Abstract][Full Text] [Related]
20. Nicotine exacerbates atherosclerosis and plaque instability via NLRP3 inflammasome activation in vascular smooth muscle cells.
An J; Ouyang L; Yu C; Carr SM; Ramprasath T; Liu Z; Song P; Zou MH; Ding Y
Theranostics; 2023; 13(9):2825-2842. PubMed ID: 37284455
[No Abstract] [Full Text] [Related]
[Next] [New Search]
